/
Sensus Healthcare, Inc. (together, with its subsidiaries, Sensus Medical Devices Ltd. and Sensus Healthcare Services, LLC, unless the context otherwise indicates, Sensus, we, us, our, or the Company ) is a medical device company committed to providing highly effective, non-invasive treatments for non-melanoma skin cancer (NMSC) and post-surgical keloid scar prevention. The Company uses a propri…
The business is unprofitable at the operating level (-37.50% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 34.3% YoY. Margins deteriorated 56.9pp alongside, both lines moving the wrong way.
ROIC dropped from 10.78% to -15.51%, capital efficiency is deteriorating. Operating margin contracted 56.9pp YoY, cost discipline may be slipping.
Profitability & Returns
Revenue (TTM)
$23M
▼ -34.3% YoY
Net Income (TTM)
-$8M
▼ -216.1% YoY
Op. Margin
-53.34%
▼ -56.9pp YoY
ROIC
-19.09%
▼ -26.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$740K
▲ +130.0% YoY
Op. Cash Flow (TTM)
-$548K
▲ +163.5% YoY
Net Debt
-$18M
Net Cash Position
Cash & Equiv.
$18M
5Y CAGR: +23.5%
Continue Research